跳至主要内容
临床试验/NCT06988501
NCT06988501招募中不适用

The Effect of Goal Setting With Mobile-based Self-management Tool on Improving Diet Quality of People With High Blood Pressure: a Randomized Controlled Trial

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2024年7月2日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
110
试验地点
1
主要终点
Diet quality

研究概览

简要总结

SMART goal setting is a patient-led method that can help improve execution and facilitate behavioral changes. Functions such as diet tracking, interaction, and feedback in smartphone application may help enhance patient compliance. This study aims to explore the nutrition intervention measures of SMART goal setting combined with smartphone applications for daily self-management on the effect of improving diet quality of people with high blood pressure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20-70;
  • Hypertension diagnosis, or high blood pressure (SBP between 120-139 mmHg and/or DBP between 80-89 mmHg);
  • Eating an unhealthy diet (estimated DASH score < 6) ;
  • Owning a smartphone and able to operate it proficiently;
  • Sign the informed consent.

排除标准

  • Severe cardiovascular and respiratory diseases, such as acute myocardial infarction, tachyarrhythmia, pulmonary edema, and severe aortic stenosis;
  • Acute phase of cardiovascular and cerebrovascular diseases;
  • Uncontrolled blood pressure;
  • Diagnosed mental diseases or epilepsy;
  • Cardiac pacemaker implantation;
  • Allergic constitutions;
  • Pregnant women or planning to become pregnant;
  • Individuals who have participated in other clinical studies within the past 3 months;
  • Refuse to sign the informed consent.

结局指标

主要结局

Diet quality

时间窗: From enrollment to the end of treatment at 12 weeks

Diet quality is measured by the DASH Score that includes eight dietary components to reflect the adherence to the DASH dietary pattern.

次要结局

  • Blood pressure(From enrollment to the end of treatment at 12 weeks)
  • Body Weight(From enrollment to the end of treatment at 12 weeks)

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验